Literature DB >> 23813607

The natural history of sickle cell disease.

Graham R Serjeant1.   

Abstract

The term sickle cell disease embraces a group of genetic conditions in which pathology results from the inheritance of the sickle cell gene either homozygously or as a double heterozygote with another interacting gene. The spectrum of resulting conditions is therefore influenced by the geography of individual hemoglobin genes, but in most populations, the commonest genotype at birth is homozygous sickle cell (SS) disease. Because this genotype generally manifests a greater mortality, the relative proportion of sickle cell genotypes is influenced by age as well as the geographical distribution of individual genes.

Mesh:

Substances:

Year:  2013        PMID: 23813607      PMCID: PMC3784812          DOI: 10.1101/cshperspect.a011783

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  47 in total

1.  The haematology of homozygous sickle cell disease after the age of 40 years.

Authors:  J Morris; D Dunn; M Beckford; Y Grandison; K Mason; D Higgs; K De Ceulaer; B Serjeant; G Serjeant
Journal:  Br J Haematol       Date:  1991-03       Impact factor: 6.998

2.  Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study.

Authors:  K J Wierenga; I R Hambleton; N A Lewis
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

3.  Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Authors:  Martin H Steinberg; Franca Barton; Oswaldo Castro; Charles H Pegelow; Samir K Ballas; Abdullah Kutlar; Eugene Orringer; Rita Bellevue; Nancy Olivieri; James Eckman; Mala Varma; Gloria Ramirez; Brian Adler; Wally Smith; Timothy Carlos; Kenneth Ataga; Laura DeCastro; Carolyn Bigelow; Yogen Saunthararajah; Margaret Telfer; Elliott Vichinsky; Susan Claster; Susan Shurin; Kenneth Bridges; Myron Waclawiw; Duane Bonds; Michael Terrin
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

4.  Haematological response to parvovirus B19 infection in homozygous sickle-cell disease.

Authors:  B E Serjeant; I R Hambleton; S Kerr; C G Kilty; G R Serjeant
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

5.  Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure.

Authors:  Timothy L McCavit; Charles T Quinn; Chonnamet Techasaensiri; Zora R Rogers
Journal:  J Pediatr       Date:  2010-12-28       Impact factor: 4.406

6.  Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.

Authors:  M Seakins; W N Gibbs; P F Milner; J F Bertles
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

7.  The development of haematological changes in homozygous sickle cell disease: a cohort study from birth to 6 years.

Authors:  G R Serjeant; Y Grandison; Y Lowrie; K Mason; J Phillips; B E Serjeant; S Vaidya
Journal:  Br J Haematol       Date:  1981-08       Impact factor: 6.998

8.  Priapism and impotence in homozygous sickle cell disease.

Authors:  A M Emond; R Holman; R J Hayes; G R Serjeant
Journal:  Arch Intern Med       Date:  1980-11

9.  Observations on the natural history of dactylitis in homozygous sickle cell disease.

Authors:  M C Stevens; M Padwick; G R Serjeant
Journal:  Clin Pediatr (Phila)       Date:  1981-05       Impact factor: 1.168

10.  Periodic transfusions for sickle cell anemia and CNS infarction.

Authors:  S Sarnaik; D Soorya; J Kim; Y Ravindranath; J Lusher
Journal:  Am J Dis Child       Date:  1979-12
View more
  73 in total

1.  Review of Medication Therapy for the Prevention of Sickle Cell Crisis.

Authors:  Tanya R Riley; Angelo Boss; Dominique McClain; Treavor T Riley
Journal:  P T       Date:  2018-07

2.  A locus on chromosome 5 shows African ancestry-limited association with alloimmunization in sickle cell disease.

Authors:  Lesedi M Williams; Zhihua Qi; Ken Batai; Stanley Hooker; Nancy J Hall; Roberto F Machado; Alice Chen; Sally Campbell-Lee; Yongtao Guan; Rick Kittles; Neil A Hanchard
Journal:  Blood Adv       Date:  2018-12-26

Review 3.  Classification of the disorders of hemoglobin.

Authors:  Bernard G Forget; H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

4.  A diagnostic role for dense cells in sickle cell disease.

Authors:  Natasha M Archer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

Review 5.  Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data.

Authors:  Angela Rivers; Ramasamy Jagadeeswaran; Donald Lavelle
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-08-01       Impact factor: 3.619

6.  Red blood cell indices and prevalence of hemoglobinopathies and glucose 6 phosphate dehydrogenase deficiencies in male Tanzanian residents of Dar es Salaam.

Authors:  Solomon Mwakasungula; Tobias Schindler; Said Jongo; Elena Moreno; Kasimu Kamaka; Mgeni Mohammed; Selina Joseph; Ramla Rashid; Thabit Athuman; Anneth Mwasi Tumbo; Ali Hamad; Omar Lweno; Marcel Tanner; Seif Shekalaghe; Claudia A Daubenberger
Journal:  Int J Mol Epidemiol Genet       Date:  2014-12-15

7.  A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.

Authors:  Nathaniel Z Piety; Xiaoxi Yang; Dalia Lezzar; Alex George; Sergey S Shevkoplyas
Journal:  Am J Hematol       Date:  2015-03-30       Impact factor: 10.047

8.  A preliminary investigation of the psychometric properties of PROMIS® scales in emerging adults with sickle cell disease.

Authors:  Aimee K Hildenbrand; Charles T Quinn; Constance A Mara; James L Peugh; Emily A McTate; Maria T Britto; Lori E Crosby
Journal:  Health Psychol       Date:  2019-05       Impact factor: 4.267

9.  Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy.

Authors:  Mohsen Saleh ElAlfy; Amira Abdel Moneam Adly; Fatma Soliman ElSayed Ebeid; Deena Samir Eissa; Eman Abdel Rahman Ismail; Yasser Hassan Mohammed; Manar Elsayed Ahmed; Aya Sayed Saad
Journal:  Immunol Res       Date:  2018-08       Impact factor: 2.829

Review 10.  Hemoglobin variants: biochemical properties and clinical correlates.

Authors:  Christopher S Thom; Claire F Dickson; David A Gell; Mitchell J Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.